Topics

Glioblastoma | Outcomes | Temozolomide

Home > Publications > Topics > Glioblastoma > Outcomes > Temozolomide

Inggas MAM, Patel U, Wijaya JH, Otinashvili N, Menon VR, Iyer AK, Turjman T, Dadwal S, Gadaevi M, Ismayilova A, Gaddam SJ, Arya P, Upadhyay N, Kataria S.
The role of temozolomide as adjuvant therapy in glioblastoma management: a systematic review and meta-analysis.
BMC Cancer. 2025 Mar 5;25(1):399. doi: 10.1186/s12885-025-13757-1. PMID: 40045273. Review; Meta-analysis. ˍ

Raghu A, Killar S, Cohen AL.
Effects of temozolomide dosing on outcome in glioblastoma.
J Neurooncol. 2025 Nov 19;176(1):89. doi: 10.1007/s11060-025-05324-2. PMID: 41258619. Observational study. ˍ